Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K170772
    Manufacturer
    Date Cleared
    2017-06-07

    (85 days)

    Product Code
    Regulation Number
    866.1640
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Liofilchem® MIC Test Strip (MTS) is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in ug/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures.

    The Clindamycin MTS at concentrations of 0.016-256 ug/mL should be interpreted at 16-20 hours of incubation.

    The non-fastidious bacteria that have been shown to be active both clinically and in vitro against Clindamycin according to the FDA label are:

    Staphylococcus aureus (methicillin-susceptible strains)

    Device Description

    MTS consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent.

    AI/ML Overview

    I am sorry, but the provided text describes an FDA 510(k) premarket notification for an antimicrobial susceptibility test strip (Liofilchem MIC Test Strip, Clindamycin). This document is a regulatory approval letter and does not contain the detailed study information needed to answer your questions about acceptance criteria and device performance in the context of an AI/machine learning study.

    The document discusses:

    • The device: Liofilchem MIC Test Strip (MTS), Clindamycin 0.016 - 256μg/mL
    • Its purpose: In vitro determination of antimicrobial susceptibility of bacteria.
    • Regulation and product codes.
    • General controls provisions for marketed devices.
    • Indications for Use: Specifically for Staphylococcus aureus (methicillin-susceptible strains) against Clindamycin, with incubation and manual reading procedures.

    It does not include any information about:

    • A table of acceptance criteria or reported device performance for an AI/ML system.
    • Sample sizes for test or training sets related to an AI/ML model.
    • Data provenance (e.g., country of origin, retrospective/prospective).
    • Number or qualifications of experts used to establish ground truth for AI/ML.
    • Adjudication methods for AI/ML test sets.
    • Multi-reader multi-case (MRMC) comparative effectiveness studies with AI assistance.
    • Standalone algorithm performance.
    • Type of ground truth (e.g., pathology, outcomes data) for an AI/ML study.
    • How ground truth was established for training sets in an AI/ML context.

    Therefore, I cannot provide an answer that meets your requirements based on the given input.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1